STOCK TITAN

Atara Biotherapeutics, Inc (ATRA) Net Income by Year

ATRA

Atara Biotherapeutics, Inc reported $32.7M in net income in fiscal year 2025. This represents an increase of 138.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $16.7M net loss. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Atara Biotherapeutics, Inc has filed alongside them.

FY2025 annual
Net Income $32.7M
YoY +138.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ATRA Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Net Income-$16.7M$32.7M+138.3%-$85.4M+69.1%-$276.1M-20.9%-$228.3M+32.9%-$340.1M-10.9%-$306.6M-5.4%-$291.0M-26.1%-$230.7M-93.1%-$119.5M-51.2%-$79.0M-38.1%-$57.2M-104.3%-$28.0M-219.2%-$8.8M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

ATRA Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$4.8M-302.5%-$4.1M-110.9%-$3.4M+73.2%-$4.3M+80.4%$2.4M+112.5%$38.0M+219.7%-$12.7M+79.0%-$21.9M+68.6%-$19.0M+73.2%-$31.8M+57.5%-$60.5M+18.9%-$69.8M+17.0%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Atara Biotherapeutics, Inc financials

Frequently Asked Questions

What was Atara Biotherapeutics, Inc's net income in fiscal year 2025?

Atara Biotherapeutics, Inc reported $32.7M in net income in fiscal year 2025.

How fast is Atara Biotherapeutics, Inc's net income growing?

Atara Biotherapeutics, Inc (ATRA) net income rose by 138.3% year over year, from -$85.4M to $32.7M in fiscal year 2025.

What is Atara Biotherapeutics, Inc's net income over the last twelve months?

Atara Biotherapeutics, Inc (ATRA) reported a $16.7M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 13 fiscal years this page covers, Atara Biotherapeutics, Inc (ATRA) net income went from -$8.8M in fiscal year 2013 to $32.7M in fiscal year 2025.

Atara Biotherapeutics, Inc (ATRA) reported -$4.8M in net income in Q2 2026. This represents a decrease of 302.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Atara Biotherapeutics, Inc (ATRA) reported on that line in every period on record.